Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-28 @ 12:26 AM
Study NCT ID:
NCT04339595
Status:
TERMINATED
Last Update Posted:
2021-12-08
First Post:
2020-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis
Sponsor:
Almirall, S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-25
First Submit QC Date:
None
Study First Post Date:
2020-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-25
Last Update Post Date:
2021-12-08
Last Update Post Date Type:
ACTUAL